John Trzupek

Chief Operating Officer at

Abata Therapeutics, Inc.

Consumer Services

Finance

Health Technology

Profile

Dr. John Trzupek is a Managing Director at Bain Capital Life Sciences LP and a Chief Operating Officer at Abata Therapeutics, Inc. He received his undergraduate degree from Northwestern University, an MBA from the University of Chicago Booth School of Business and a doctorate degree from The Scripps Research Institute.

John Trzupek active positions

Companies	Position	Start
Abata Therapeutics, Inc. Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases	Chief Operating Officer	-
Bain Capital Life Sciences LP Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million.	Private Equity Investor	01/10/2025

All active positions of John Trzupek

Training of John Trzupek

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Trzupek's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
The Scripps Research Institute The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Northwestern University Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Bain Capital Life Sciences LP Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million.	Finance
Abata Therapeutics, Inc. Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases	Health Technology